Oral Antipsychotic Therapy in the ICU

Primary Recommendation

• The Society of Critical Care Medicine recommends against routine antipsychotic use for delirium treatment in ICU patients due to lack of proven efficacy on duration of delirium, mechanical ventilation, ICU length of stay, or mortality 1

Essential Management Principles

• The Society of Critical Care Medicine suggests maximizing non-pharmacologic interventions, including family presence, reorientation, minimizing restraints, maintaining normal sleep-wake cycles, and early mobilization when feasible 1, 2
• Address reversible causes of delirium first, such as evaluating and correcting hypoxia, urinary retention, constipation, and metabolic disturbances 2
• Review all medications for anticholinergic burden and drug interactions that may worsen delirium 2

Critical Contraindications

• The guideline recommends avoiding haloperidol entirely in patients with Parkinson's disease due to severe risk of extrapyramidal symptoms and potential neuroleptic malignant-like syndrome 2

Common Pitfalls to Avoid

• The Society of Critical Care Medicine advises against using antipsychotics routinely for all ICU delirium, as this practice lacks evidence for improving meaningful outcomes and may expose patients to unnecessary adverse effects 1, 3
• Haloperidol has no adequately powered randomized controlled trials establishing efficacy or safety for delirium treatment in ICU patients 3, 2

Management of ICU Psychosis

Pharmacologic Interventions

• The Society of Critical Care Medicine recommends against routine antipsychotic use, including risperidone, for delirium treatment because there is no evidence that antipsychotics reduce duration of delirium, mechanical ventilation time, ICU length of stay, or mortality, with some evidence suggesting atypical antipsychotics like quetiapine may reduce delirium duration in adult ICU patients 4
• Both risperidone and diphenhydramine can prolong the QT interval, and the Society of Critical Care Medicine advises against using antipsychotics in patients at significant risk for torsades de pointes, including those receiving concomitant medications known to prolong the QT interval 5, 6
• Dexmedetomidine is preferred over benzodiazepines for sedation in ICU patients with delirium unrelated to alcohol or benzodiazepine withdrawal, as it may reduce the duration of delirium by approximately 20% 6

Cardiac Considerations

• Torsades de pointes has been reported with risperidone, and drug interactions can heighten this risk, particularly when combined with medications like diphenhydramine that also prolong the QT interval 5, 6

Risperidone Usage in ICU

Primary Recommendation Against Routine Use

• The Society of Critical Care Medicine recommends against routine antipsychotic use, including risperidone, for delirium treatment in ICU patients due to lack of proven efficacy on meaningful clinical outcomes, with one moderate-quality study suggesting a single dose of sublingual risperidone immediately postoperatively reduced delirium incidence in cardiac surgery patients 7, 8, 9

Mandatory Safety Contraindications

• Patients at risk for torsades de pointes, including those with baseline QT prolongation, concomitant QT-prolonging medications, or history of this arrhythmia, should not be given risperidone in ICU settings, as torsades de pointes has been specifically reported with risperidone, and drug interactions heighten this risk 8, 10

Critical Pitfalls to Avoid

• Risperidone should not be used prophylactically to prevent delirium in general ICU populations, as no high-quality evidence supports this practice, and the evidence for risperidone in ICU settings is notably weak, with one moderate-quality study showing benefit only for single-dose prophylaxis in cardiac surgery patients 7, 9
• Early mobilization when feasible is a preferred management algorithm for ICU delirium, as part of non-pharmacologic interventions, according to the Society of Critical Care Medicine 9

ICU Delirium Management – Antipsychotic Use Recommendations

Guideline Stance on Routine Antipsychotic Therapy

• The Society of Critical Care Medicine recommends against routine use of antipsychotics for ICU delirium because they have not demonstrated benefit on mortality, duration of mechanical ventilation, or ICU length of stay. Strength: guideline recommendation (no specific grade). 11

Evidence Supporting Quetiapine in ICU Delirium

• Quetiapine has Level C evidence from a prospective, randomized, double‑blind, placebo‑controlled trial (36 patients) showing a significant reduction in delirium duration (36 h vs 120 h, p = 0.006) and a faster time to first resolution (1.0 day vs 4.5 days, p = 0.001) when added to as‑needed haloperidol. Strength: Level C. 11

• Quetiapine’s sedating properties may be advantageous for hyperactive delirium, though they increase the risk of somnolence (≈22 % vs 11 %). Strength: observational data (no grade assigned). [12][13]14

• Quetiapine is available only in oral formulations, which can limit use in acutely agitated patients unable to take oral medication. Strength: formulation limitation noted in guideline. [12][13]14

Evidence (or Lack Thereof) for Aripiprazole in ICU Delirium

• Aripiprazole is supported only by Level IV evidence; no ICU‑specific randomized controlled trials have demonstrated efficacy. Strength: Level IV. [12][13]14

• Although parenteral formulations of aripiprazole exist in some countries, no adequately powered ICU trials have evaluated its effectiveness. Strength: lack of trial data. [12][13]14

When Antipsychotics May Be Considered

• Pharmacologic antipsychotics should be reserved for ICU patients who exhibit distressing delirium symptoms (e.g., perceptual disturbances or hallucinations causing fear) or who pose safety risks to themselves or others. Strength: guideline indication. 12

• When used, clinicians should employ the lowest effective dose for the shortest possible duration. Strength: guideline recommendation. [12][13]14

Safety Contraindications for Both Quetiapine and Aripiprazole

• Avoid either agent in patients with baseline QT‑interval prolongation or a history of torsades de pointes. Strength: safety warning. [15][12][13][14]

Preferred Non‑Antipsychotic Pharmacologic Strategy

• For mechanically ventilated ICU patients with delirium not related to alcohol or benzodiazepine withdrawal, dexmedetomidine is preferred over benzodiazepines, as it reduces delirium duration by roughly 20 % compared with benzodiazepine sedation. Strength: guideline recommendation (based on trial data). 15

Prophylactic Antipsychotic Use – Not Recommended

• Prophylactic administration of antipsychotics in the general ICU population is not supported by high‑quality evidence and should be avoided. Strength: guideline recommendation. 11

Agents Contraindicated in ICU Delirium

• Rivastigmine (a cholinesterase inhibitor) has been associated with more severe and longer delirium and a trend toward higher mortality; a Level ‑1B recommendation advises against its use in ICU delirium. Strength: Level ‑1B recommendation. [11][15]